PALATIN TECHNOLOGIES INC (PTN)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$12.70-2.91%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · PTN
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenues | — | — | 4.5 | 4.9 | 1.5 |
| Total Revenues | — | — | 4.5 | 4.9 | 1.5 |
| Cost of Revenues | — | — | 0.1 | 0.4 | 0.2 |
| Operating Expenses & Income | |||||
| Selling, General & Admin | — | 7.8 | 12.3 | 15.3 | 16.5 |
| R&D Expenses | 12.3 | 14.9 | 22.4 | 22.6 | 21.3 |
| Operating Income | (6.5) | (17.5) | (22.5) | (32.5) | (36.6) |
| Earnings from Continuing Operations | |||||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other Non-Operating Income / Expenses | — | — | — | — | 0.4 |
| EBT, Incl. Unusual Items | — | — | — | (32.2) | (36.2) |
| Income Tax Expense | — | — | — | (4.7) | 0.0 |
| Net Income | |||||
| Net Income | 28.4 | (17.3) | (29.7) | 36.2 | (36.2) |
| Per Share | |||||
| Basic EPS | 7.25 | — | (2.02) | (2.21) | — |
| Diluted EPS | 7.25 | (32.15) | — | — | — |
| Basic Weighted Avg Shares | 3.9 | — | 14.7 | 10.9 | — |
| Diluted Weighted Avg Shares | 3.9 | 0.5 | — | — | — |
| Supplemental | |||||
| EBITDA | — | (17.2) | (22.2) | (32.2) | (36.5) |
| EBIT | (6.5) | (17.5) | (22.5) | (32.5) | (36.6) |
| Effective Tax Rate | — | — | — | 14.5% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.